Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and absolute oral bioavailability of GSK1325756 given as an infusion and as an oral dose in h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• GSK1325756

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Respiratory Tract | Phase 1 | Status: COMPLETED